The Rivals Who Arrived by Cheque BookNarrow moat

In March 2021 Allianz agreed to buy Aviva's Polish and Lithuanian operations for more than 2,5 billion euros. It was the largest acquisition Allianz had made anywhere in ten years. By the end of 2022 the mergers and rebranding were complete, the Aviva name had disappeared from Poland altogether, and Allianz had become the country's second-largest life insurer, sixth-largest in non-life, fourth in mutual funds and second in pensions¹.

That transaction is the clearest illustration of how this market actually changed. Uniqa acquired AXA's Polish business. Generali bought Concordia. Each deal removed a mid-sized competitor and added its book to a larger foreign group. The number of insurance brands a Polish customer might choose from fell; the average financial strength behind each one rose.

For PZU this is a mixed inheritance. Fewer, larger competitors is generally better than many small ones — a fragmented market is a price war waiting for a participant desperate enough to start it. But a subsidiary of Allianz or Munich Re can price below its cost of capital in Poland for as long as its parent judges the market strategically important, and the parent's judgement is made in a boardroom weighing Poland against Brazil and Turkey. PZU has no such option and no such distraction: Poland is not one of its markets, it is the whole business.

There is a symmetry worth naming. PZU's own growth has come from acquisitions too — of banks rather than insurers, and directed by a state shareholder rather than a return calculation, which is the subject of the moat's State-Ownership Overhang threat.

Watch for the reverse transaction. A global group deciding Polish insurance no longer earns its capital, and selling, would tell you more about the industry's returns than any market-share table.